Modulating the vascular response to limb ischemia: angiogenic and cell therapies.
about
Mitochondrial Regulation of the Muscle Microenvironment in Critical Limb IschemiaEndothelial colony forming cells and mesenchymal progenitor cells form blood vessels and increase blood flow in ischemic muscle.The Promise and Challenge of Induced Pluripotent Stem Cells for Cardiovascular Applications.Resolvin D2 Enhances Postischemic Revascularization While Resolving Inflammation.Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation.Hypoxic preconditioning-induced autophagy enhances survival of engrafted endothelial progenitor cells in ischaemic limb.Stem cell-based therapies to promote angiogenesis in ischemic cardiovascular disease.Vascular Regeneration in Ischemic Hindlimb by Adeno-Associated Virus Expressing Conditionally Silenced Vascular Endothelial Growth FactorStem cell-derived vasculature: A potent and multidimensional technology for basic research, disease modeling, and tissue engineering.Medical Therapy in Peripheral Artery Disease and Critical Limb Ischemia.Contemporary evaluation and management of lower extremity peripheral artery disease.Adenosine triphosphate is a critical determinant for VEGFR signal during hypoxia.Endoglin-based biological therapy in the treatment of angiogenesis-dependent pathologies.Treatment of hind limb ischemia using angiogenic peptide nanofibersA compendium on peripheral arterial disease.Loss of PHD3 in myeloid cells dampens the inflammatory response and fibrosis after hind-limb ischemia.Diminished force production and mitochondrial respiratory deficits are strain-dependent myopathies of subacute limb ischemia.Cell Therapy and Critical Limb Ischemia: Evidence and Window of Opportunity in Obesity.Adenoviral intramyocardial VEGF-DΔNΔC gene transfer increases myocardial perfusion reserve in refractory angina patients: a phase I/IIa study with 1-year follow-up.Carbon dioxide water-bath treatment augments peripheral blood flow through the development of angiogenesis.Concise Review: Cell Therapy for Critical Limb Ischemia: An Integrated Review of Preclinical and Clinical Studies.YAP/TAZ-CDC42 signaling regulates vascular tip cell migration.Cell therapy for peripheral artery disease.Epigenetic Activation of Pro-angiogenic Signaling Pathways in Human Endothelial Progenitors Increases Vasculogenesis.Every PACE Counts: Learning About Blood Cells and Blood Flow in Peripheral Artery Disease.Robust Revascularization in Models of Limb Ischemia Using a Clinically Translatable Human Stem Cell-Derived Endothelial Cell Product.Chronic hyperuricemia impairs blood flow recovery in the ischemic hindlimb through suppression of endothelial progenitor cells.Therapeutic Angiogenesis of Chinese Herbal Medicines in Ischemic Heart Disease: A Review.Aryl Hydrocarbon Receptor Nuclear Translocator in Vascular Smooth Muscle Cells Is Required for Optimal Peripheral Perfusion Recovery.ImmunoPET of CD146 in a Murine Hindlimb Ischemia ModelPericyte-Specific Ninjurin1 Deletion Attenuates Vessel Maturation and Blood Flow Recovery in Hind Limb IschemiaDrug-Free ROS Sponge Polymeric Microspheres Reduce Tissue Damage from Ischemic and Mechanical InjuryA Scalable and Efficient Bioprocess for Manufacturing Human Pluripotent Stem Cell-Derived Endothelial Cells
P2860
Q26774784-87855EB5-7A8A-4E2A-B611-5FF8DA57EEDAQ33677801-E4A1F53F-8F7B-40FD-9275-E863C283E382Q33748399-90C95654-7BAA-4185-84F8-649258E8351DQ34536887-71D16D58-95DD-4ED2-AB2D-138BD188A63BQ36193664-4091A773-A1C2-4C77-BE3B-2533935A4BE2Q36333615-868AE7D3-EDE8-4AAA-B2C4-23311041672FQ36699597-68D601B9-545E-4CEB-9ABB-0F45BDC23B1DQ37076027-24D71E2F-3BD4-4A97-83F9-643BB6D8C283Q38597068-7B52564F-1229-4825-9B86-04B9E38CB5E5Q38834990-BAB6F14C-0034-4B7E-ABCA-3B6736312112Q38850458-2E67BE6A-FF52-4D84-BCC5-D19563FFA28DQ39196795-64AFAEDD-A7BD-441B-A4E8-83631C8603CAQ39401943-5E395F0F-8283-4616-8BD4-94881E8DF92CQ39763708-EE464384-F163-4FAB-ADB0-45A173919CCFQ39968344-3E0970A3-B478-4639-96CD-8E3F5BC64641Q41169352-A1D6B162-9F0C-423A-B035-939F33887479Q41361706-2628A29F-888A-495C-85C2-F4FE711E583EQ41813965-E3E7AECF-62B8-4AEB-98ED-9506A3B24800Q45252610-B364A5FF-5D45-4A41-90D7-3A4A0DA70FDDQ47973482-4A479126-E06D-432B-AF65-14612A2D8ABAQ48144378-7CB04430-9614-4172-B770-299E868D9ABEQ49647076-2108224A-27CC-452D-9610-3C1115B42D6FQ49917431-F682AFF0-18B3-4091-9BF4-65BC03F15F03Q50071790-4CA92362-03AB-43CF-94F1-AAC1F470F9DCQ50445041-0AB7CD36-D416-44F6-BCBB-92F88AC2DE41Q52716131-98A08790-3851-4F88-9DC3-F0533FD5C1A1Q52728686-136F18AF-F667-4AA9-94E6-DEC3204BA998Q54969538-34FD442D-3D9A-4A96-8274-5B443E705C28Q55432006-4E2A0399-B401-439E-83D7-420D64479838Q57170632-363E161C-6FE9-48A3-A62D-EBAE44130869Q57818472-D418BA83-8B71-4AFE-803B-A09F50E9CAB3Q57825832-860FC15F-1A42-42F4-91E1-CD9E7AAA2669Q58803059-30180141-3409-4517-A472-2C3A4B792046
P2860
Modulating the vascular response to limb ischemia: angiogenic and cell therapies.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Modulating the vascular response to limb ischemia: angiogenic and cell therapies.
@en
type
label
Modulating the vascular response to limb ischemia: angiogenic and cell therapies.
@en
prefLabel
Modulating the vascular response to limb ischemia: angiogenic and cell therapies.
@en
P2860
P1433
P1476
Modulating the vascular response to limb ischemia: angiogenic and cell therapies
@en
P2093
Douglas W Losordo
P2860
P304
P356
10.1161/CIRCRESAHA.115.303565
P577
2015-04-01T00:00:00Z